Relation of obesity and cardiovascular risk in Spain

J Millán Núñez-Cortés1

  • 1Chair of Internal Medicine, School of Medicine, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. jesus.millan@salud.madrid.org

Insights

Cardiovascular diseases are a leading cause of death in Spain, driven by risk factors like high blood pressure and obesity. This study models global cardiovascular risk, emphasizing obesity

Area of Science:

  • Cardiology and Public Health

Background:

  • Cardiovascular diseases (CVDs) are the primary cause of mortality in Spain.
  • High prevalence of cardiovascular risk factors, including hypertension, dyslipidemia, smoking, obesity, and diabetes, contributes significantly to CVDs.
  • The clustering of cardio-metabolic risk factors amplifies individual global cardiovascular risk.

Purpose of the Study:

  • To evaluate the impact of obesity and overweight on other cardiovascular risk factors.
  • To establish the relative contribution of obesity to an individual's overall cardiovascular risk.
  • To develop a model for calculating global cardiovascular risk in the Spanish population.

Main Methods:

  • Analysis of epidemiological studies involving approximately 15,000 Spanish adults across nine autonomous communities.
  • Assessment of the prevalence of various cardiovascular risk factors.
  • Development of a qualitative-quantitative model integrating risk factor prevalence and relative risks.

Main Results:

  • Quantified the prevalence of key cardiovascular risk factors in the Spanish adult population.
  • Determined the relative weight of obesity and overweight in the context of other cardiovascular risk factors.
  • Established associations between obesity, overweight, and other cardio-metabolic risk factors.

Conclusions:

  • Obesity and overweight play a significant role in increasing overall cardiovascular risk in Spain.
  • The developed model provides a tool for calculating global cardiovascular risk tailored to the Spanish population.
  • Understanding the interplay of risk factors, particularly obesity, is crucial for public health strategies targeting CVD prevention.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...